Abstract
The aim of the present study was to evaluate the long-term outcomes at 2 years in patients in whom everolimus-eluting stents (EESs) were implanted in small and non-small vessels. A small vessel is an important risk factor for restenosis with BMSs, even in the first generation DESs. The 690 patients with 690 lesions implanted with an EES were enrolled and divided into two groups by vessel reference diameter (RD): >2.5 mm for non-small vessels (Non-S-group) and ≤2.5 mm for small vessels (S-group). Two years later, the 365 patients with no restenosis at 8 months who underwent angiography were enrolled into the late catch-up study. At the initial 8-month follow-up, the rates of restenosis and target lesion revascularization (TLR) of both groups were not significantly different (restenosis 3.9 vs 6.5%, p = 0.17; TLR 3.9 vs 6.5%, p = 0.17). At the late 2-year follow-up, there were no significant differences in the late loss (0.36 ± 0.66 vs 0.34 ± 0.50 mm, p = 0.14), net gain (1.50 ± 0.75 vs 1.26 ± 0.60 mm, p = 0.39), late catch-up restenosis rate (5.1 vs 3.4%, p = 0.38), TLR (4.9 vs 2.7%, p = 0.40), and delayed late loss (0.14 ± 0.58 vs 0.15 ± 0.49 mm, p = 0.10) between both groups. There is no correlation between delayed late loss and RD in all patients(r = −0.009) and in AMI patients (r = −0.004). These results demonstrate that the initial and late catch-up restenosis rates of small coronary vessels with EES placement were excellent, the same as for non-small coronary vessels. We suggest that involvement of small coronary arteries may not be a risk factor for restenosis and results of stenting for small coronary arteries with EES placement were excellent.
Similar content being viewed by others
References
Picchi A, Musumeci G, Calabria P, Cresti A, Rescigno R, Aruffo A, Prati F, Limbruno U (2015) Comparison of strut coverage at 6 months by optical coherence tomography with everolimus-eluting stenting of bare-metal stent restenosis versus stenosis of nonstented atherosclerotic narrowing (from the DESERT study). Am J Cardiol 115:1351–1356
Yoshida T, Sakata K, Nitta Y, Taguchi T, Kaku B, Katsuda S, Shimojima M, Gamou T, Nakahashi T, Konno T, Kawashiri MA, Yamagishi M, Hayashi K (2016) Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries. Heart Vessels 31(5):635–642
Piccolo R, Stefanini GG, Franzone A, Spitzer E, Blöchlinger S, Heg D, Jüni P, Windecker S (2015) Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis. Circ Cardiovasc Interv 8(4):e002778
Lai CL, Wu CF, Kuo RN, Yang YY, Chen MF, Chan KA, Lai MS (2015) Clinical outcomes in low risk coronary artery disease patients treated with different limus-based drug-eluting stents—a nationwide retrospective cohort study using insurance claims database. PLoS One 10:e0122860
Qi-Hua L, Qi Z, Yu Z, Xiao-Long L, Hai-Gang J, Jian-Feng Y, Yi S (2015) Long-term effect of second-generation drug-eluting stents for coronary artery disease, everolimus-eluting versus zotarolimus-eluting stents: a meta-analysis. Coron Artery Dis 26:259–265
Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO (2015) 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial). Catheter Cardiovasc Interv 86(7):1161–1167
Kubo S, Kadota K, Otsuru S, Hasegawa D, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K (2015) Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure. EuroIntervention 10:e1–e8
Lee S, Yoon CH, Oh IY, Suh JW, Cho YS, Cho GY, Chae IH, Choi DJ, Youn TJ (2015) Angiographic patterns of restenosis with 2nd generation drug-eluting stent. Int Heart J 56:6–12
Chieffo A, Buchanan GL, Parodi G, Versaci F, Bianchi RM, Valenti R, Saccà S, Mongiardo A, Span S, Migliorini A, Spaccarotella C, Reimers B, Antoniucci D, Indolfi C, Ferrari A, Maehara A, Mintz GS, Colombo A (2014) Drug-eluting stent implantation in patients with acute coronary syndrome—the activity of platelets after inhibition and cardiovascular events: optical coherence tomography (APICE OCT) study. EuroIntervention 10:916–923
Pedersen SH, Pfisterer M, Kaiser C, Jensen JS, Alber H, Rickenbacher P, Sørensen R, Iversen A, Jensen MT, Wadt K, Galatius S (2014) Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial. EuroIntervention 10:58–64
Omar A, Torguson R, Kitabata H, Pendyala LK, Loh JP, Magalhaes MA, Satler LF, Suddath WO, Pichard AD, Waksman R (2014) Long-term safety and efficacy of second-generation everolimus-eluting stents compared to other limus-eluting stents and bare metal stents in patients with acute coronary syndrome. Catheter Cardiovasc Interv 84:1053–1060
Wang L, Zang W, Xie D, Ji W, Pan Y, Li Z, Shen J, Shi Y (2013) Drug-eluting stents for acute coronary syndrome: a meta-analysis of randomized controlled trials. PLoS One 8:e72895
Puymirat E, Mangiacapra F, Peace A, Ntarladimas Y, Conte M, Bartunek J, Vanderheyden M, Wijns W, de Bruyne B, Barbato E (2013) Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. Arch Cardiovasc Dis 106:554–561
Kereiakes DJ, Cannon LA, Dauber I, Ball M, Bertolet B, Foster M, Nersesov AY, Underwood PL, Allocco DJ, Dawkins KD (2015) Long-term follow-up of the platinum chromium TAXUS element (ION) stent: the PERSEUS workhorse and small vessel trial five-year results. Catheter Cardiovasc Interv 86(6):994–1001
Naganuma T, Latib A, Sgueglia GA, Menozzi A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Panoulas VF, Buffoli F, Tamburino C, Varbella F, Colombo A (2015) A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study. Int J Cardiol 184:17–21
Puymirat E, Barbato E (2014) Percutaneous revascularization strategies in small-vessel disease. Ann Cardiol Angeiol 63:28–31
Tajiri K, Sato A, Hoshi T, Kimura T, Nakagawa Y, Sakai S, Aonuma K, Watanabe S (2014) Mechanisms explaining the late “catch-up” phenomenon after sirolimus-eluting stent implantation. Int J Cardiol 177:44–45
Sgueglia GA, Cortese B, Gaspardone A (2013) Late catch-up phenomenon after drug-eluting balloon angioplasty. Int J Cardiol 168:638–639
Iijima R, Araki T, Nagashima Y, Yamazaki K, Utsunomiya M, Hori M, Itaya H, Shinji H, Shiba M, Hara H, Nakamura M, Sugi K (2013) Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation. Int J Cardiol 168:2588–2592
Yang TH, Kim DI, Jin HY, Cho YW, Chung SR, Kim DK, Kim YB, Jang JS, Kim U, Seol SH, Kim DK, Kim DS (2012) Angiographic late catch-up phenomenon after sirolimus-eluting stent implantation. Int J Cardiol 160:48–52
Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ (2006) Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late “catch-up” phenomenon from ASPECT study. J Am Coll Cardiol 48:2432–2439
Horita Y, Namura M, Ikeda M, Tsuchiya T, Terai H, Fukuoka R, Tama N, Takagi T (2011) Which DES is the most appropriate for very small target vessels? Experimental study of stent expandable performance with SES, PES, ZES and EES. Cardiovasc Interv Ther 26:124–130
Haase J, Escaned J, van Swijndregt EM, Ozaki Y, Gronenschild E, Slager CJ, Serruys PW (1993) Experimental validation of geometric and densitometric coronary measurements on the new generation cardiovascular angiography analysis system (CAAS II). Catheter Cardiovasc Diagn 30:104–114
Kobayashi N, Ito Y, Hirano K, Yamawaki M, Araki M, Sakai T, Takimura H, Sakamoto Y, Mori S, Tsutsumi M, Takama T, Takafuji H, Maruyama T, Honda Y, Tokuda T, Makino K, Shirai S, Muramatsu T (2016) Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched study. Heart Vessels 31:1930–1942
Yano H, Horinaka S, Ishikawa M, Ishimitsu T (2016) The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up. Heart Vessels 31:1609–1615
Yano H, Horikawa S, Ishikawa M, Ishimatsu T (2016) Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up. Heart. doi:10.1007/s00380-016-0937-4
Hsieh MJ, Chen CC, Chang SH, Wang CY, Lee CH, Lin FC, Chang CJ, Hsieh IC (2013) Long-term outcomes of drug-eluting stents versus bare-metal stents in large coronary arteries. Int J Cardiol 168:3785–3790
Chan CY, Vlachos H, Selzer F, Mulukutla SR, Marroquin OC, Abbott DJ, Holper EM, Williams DO (2014) Comparison of drug-eluting and bare metal stents in large coronaries: finding from the NHLBI dynamic registry. Catheter Cardiovasc Interv 84:24–29
Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K (2013) Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-registry. J Cardiol 61:117–121
Obata JE, Nakamura T, Kitta Y, Saito Y, Sano K, Fujioka D, Kawabata K, Kugiyama K (2013) In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter. Catheter Cardiovasc Interv 82(6):E777–E787
Rathore S, Kaul U (2011) Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era. Indian Heart J 63:228–233
Hansen KW, Kaiser C, Hvelplund A, Soerensen R, Madsenn JK, Jensen JS, Pedersen SH, Eberli FR, Erne P (2013) Improved 2-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size. Int J Cardiol 169:29–34
Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K (2009) Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119:987–995
Taguchi I, Yoneda S, Abe S, Toyoda S, Nasuno T, Nishino S, Kageyama M, Tokura M, Ogawa M, Node K, Inoue T (2014) The late-phase inflammatory response after drug-eluting stent implantation. Heart Vessels 29:213–219
Hasegawa K, Tamai H, Kyo E, Kosuga K, Ikeguchi S, Hata T, Okada M, Fujita S, Tsuji T, Takeda S, Fukuhara R, Kikuta Y, Motohara S, Ono K, Takeuchi E (2006) Histopathological findings of new in-stent lesions developed beyond 5 years. Catheter Cardiovasc Interv 68:554–558
Nishiyama N, Komatsu T, Kuroyanagi T, Fujikake A, Komatsu S, Nakamura H, Yamada K, Nakahara S, Kobayashi S, Taguchi I (2016) Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease. Int J Cardol 222:113–118
Rittger H, Scheller B (2014) Drug-coated balloons in treatment of small vessel disease. Heart 100:274–275
Aoki J, Kozuma K, Awata M, Nanasato M, Shiode N, Tanabe K, Yamaguchi J, Kusano H, Nie H, Kimura T (2016) Three-year clinical outcomes of everolimus-eluting stents from the post-marketing surveillance study of cobalt-chromium everolimus-eluting stent (Xience V/PROMUS) in Japan. Circ J 80:906–912
Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ, Investigators SPIRITIII (2008) Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 299(16):1903–1913
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Tama, N., Uzui, H., Horita, Y. et al. Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study. Heart Vessels 32, 1415–1423 (2017). https://doi.org/10.1007/s00380-017-1018-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-017-1018-z